Wells Fargo & Company Arcturus Therapeutics Holdings Inc. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARCT
# of Institutions
189Shares Held
27.4MCall Options Held
320KPut Options Held
153K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$88 Million0.28% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$49.7 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.32MShares$43.4 Million0.62% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.28MShares$42.6 Million0.04% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$39.4 Million0.46% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $498M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...